Androni-Sidermec team manager Gianni Savio has confirmed that legal action will be taken against Davide Appollonio and Fabio Taborre following their positive anti-doping tests.
2. Androni-Sidermec team manager Gianni Savio has
confirmed that legal action will be taken against
Davide Appollonio and Fabio Taborre following their
positive anti-doping tests.
In August, Androni-Sidermec was suspended from
racing for 30 days under new UCI rules for the two
doping cases. The Italian team will return to action
this weekend at the Brussels Cycling Classic and GP
de Fourmies/La Voix du Nord.
3. Fabio Taborre was provisionally suspended by the UCI, the world governing
body of athletics, after he tested positive for the developmental blood booster
FG-4592. This drug was detected in an out-of-competition control on June 16.
Taborre is likely to face a €100,000 fine by his team if his positive test is
confirmed. FG-4592, also known as Roxadustat, has not yet been
commercialized and is a compound that is still in phase 3 clinical trials. FG-
4592 is taken in an oral form and has the potential of stimulating natural
production of EPO in a manner similar to altitude training unlike the drug
EPO that directly stimulates the production of red blood cells.
Taborre is the second cyclist to test positive for FG-4592 this year. Carlos
Oyarzun of Chile was found positive for FG-4592 at the Pan Am Games in
Toronto and was kicked out of the competition.
Appollonio was suspended by the UCI after testing of his June 14 out-of-
competition sample showed evidence of EPO use. Appollonio is now facing a
possible suspension of four years and may be slapped with a fine of €100,000
fine from his team and possibly additional damages under the terms and
conditions of a zero-tolerance policy that the riders signed before the 2015
season.